Suzhou Junjing Biosciences Co., Ltd.

This early-stage study tested a new drug called WJ13405 for people with advanced non-small cell lung cancer that had stopped responding to standard treatments. The trial aimed to find a safe dose and see if the drug could help control cancer growth, particularly for patients with…

This early-stage study tested a new oral medication called WJ05129 in patients with advanced solid tumors that had spread or could not be removed by surgery. The main goals were to find a safe dose and see how the body processes the drug. The study was terminated early and involv…